Astrana Health Q2 revenue rises, but misses estimates
ASTH•Result drivers
- Platform demand - Co said accelerating demand from providers and payers for its physician-centric, AI-native healthcare platform drove growth
- Value-based care expansion - Co cited expansion of Medicare Advantage footprint and new agreements in Hawaii and Texas as growth drivers
Q2 results and guidance
-
US physician-centric healthcare firm's Q2 revenue rose 49% yr/yr but missed analyst expectations
-
Q2 adjusted EPS beat analyst expectations, rising 45% yr/yr
-
Company raised full-year adjusted EBITDA guidance after strong Q2 performance
-
Astrana Health sees Q3 revenue between $1.0 bln and $1.03 bln
-
Company expects Q3 adjusted EBITDA of $72.5 mln to $77.5 mln
-
Astrana Health raises 2026 adjusted EBITDA guidance to $255 mln-$280 mln, reaffirms revenue and free cash flow outlook
